Tart Cherry

DIETARY_SUPPLEMENT7 trials

Conditions

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Breast CancerCardiovascular DiseasesDiabetesExercise RecoveryInflammationJoint PainMetabolic Syndrome

Early Phase 1

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

RecruitingNCT06123286

Philip ChangAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Joint Pain

Start: 2025-09-12End: 2027-10-01Target: 30Updated: 2026-08-04

Phase 1

Polyphenol Rich Supplementation on Markers of Recovery From Intense Resistance Exercise

NCT03540602

Jacksonville UniversityMuscle Soreness

Start: 2018-05-01End: 2018-08-31Target: 20Updated: 2018-05-30

Phase 2

Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk

CompletedNCT02154100

Florida State UniversityCardiovascular Diseases, Diabetes, Metabolic Syndrome

Start: 2014-04-30End: 2016-10-31Updated: 2016-12-08

Unknown Phase

Comparison of Acute Tart Cherry Supplement Formulation and Dose on Inflammation and Oxidative Capacity

CompletedNCT04497077

Ohio UniversityInflammation, Oxidative Stress

Start: 2015-09-15End: 2017-05-30Updated: 2020-08-04

Plasma-Induced Changes in the Metabolome Following Polyphenol Consumption

CompletedNCT06144489

Northumbria UniversityProcesses, Metabolic

Start: 2022-03-31End: 2023-04-25Updated: 2024-03-13

Recovery With Tart Cherry Supplementation Following a Marathon.

CompletedNCT06332222

Northumbria UniversityExercise Recovery

Start: 2023-04-01End: 2023-10-11Updated: 2024-03-27

Tart Cherries - The Influence on Acute Adaptation

CompletedNCT07354204

Northumbria UniversityRecovery

Start: 2023-03-01End: 2023-12-01Updated: 2026-01-21

Related Papers

Acute Ingestion of Montmorency Tart Cherry Reduces Serum Uric Acid but Has no Impact on High Sensitivity C-Reactive Protein or Oxidative Capacity.

2021-01-2710 citations